[Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
Both in a control group and in 154 patients with malignant tumors of the urogenital tract in the serum- and urinary levels of the carcinoembryonic antigen (CEA) have been ascertained by a radioimmunoassay. Serum-CEA-values lay above normal range in 71%, and urinary CEA-levels exceeded it in 46%. Only in the case of the carcinoma of the bladder a correlation was found between the CEA-curves and the clinical findings following tumor therapy. Up to the present, the CEA-test cannot be recommended as a universal screening method, but may be useful means for diagnostics and case controls, above all, with regard to the carcinoma of the bladder.
D000328:Adult; D000917:Antibody Formation; D002272:Carcinoembryonic Antigen / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology; D011863:Radioimmunoassay; D013736:Testicular Neoplasms / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology; D014565:Urogenital Neoplasms / Q000276:immunology*
D002272:Carcinoembryonic Antigen
Wertigkeit des karzinoembryonalen Antigens (CEA) für die Diagnostik maligner Tumoren des Urogenitaltraktes